Acronym
PAOx plant
Code
F2014/IOF-STEPST/215
Duration
15 January 2015 → 31 December 2017
Funding
Regional and community funding: Industrial Research Fund
Promotor
Research disciplines
-
Medical and health sciences
- Biomarker discovery and evaluation
- Drug discovery and development
- Medicinal products
- Pharmaceutics
- Pharmacognosy and phytochemistry
- Pharmacology
- Pharmacotherapy
- Toxicology and toxinology
- Other pharmaceutical sciences
Keywords
Poly(2-oxazoline)
Project description
This Stepstone project will provide us with the sufficient timeframe and resources to scale-up PAOx production and to prepare the business-model, leading to successful validation and robust commercialization of high-quality, highly defined functional PAOx under the tradename Ultroxa®.